JP2002513733A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002513733A5 JP2002513733A5 JP2000546727A JP2000546727A JP2002513733A5 JP 2002513733 A5 JP2002513733 A5 JP 2002513733A5 JP 2000546727 A JP2000546727 A JP 2000546727A JP 2000546727 A JP2000546727 A JP 2000546727A JP 2002513733 A5 JP2002513733 A5 JP 2002513733A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- vitamin
- compound
- composition according
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 26
- 229930003316 Vitamin D Natural products 0.000 description 13
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 13
- 235000019166 vitamin D Nutrition 0.000 description 13
- 239000011710 vitamin D Substances 0.000 description 13
- 229940046008 vitamin d Drugs 0.000 description 13
- -1 vitamin D compound Chemical class 0.000 description 12
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- DTXXSJZBSTYZKE-ZDQKKZTESA-N Maxacalcitol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](OCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C DTXXSJZBSTYZKE-ZDQKKZTESA-N 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- LWQQLNNNIPYSNX-UROSTWAQSA-N calcipotriol Chemical compound C1([C@H](O)/C=C/[C@@H](C)[C@@H]2[C@]3(CCCC(/[C@@H]3CC2)=C\C=C\2C([C@@H](O)C[C@H](O)C/2)=C)C)CC1 LWQQLNNNIPYSNX-UROSTWAQSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 239000010491 poppyseed oil Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- FCKJYANJHNLEEP-XRWYNYHCSA-N (24R)-24,25-dihydroxycalciol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CC[C@@H](O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C FCKJYANJHNLEEP-XRWYNYHCSA-N 0.000 description 1
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- FNJSWIPFHMKRAT-UHFFFAOYSA-N Monomethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(O)=O FNJSWIPFHMKRAT-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960002882 calcipotriol Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 210000002767 hepatic artery Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 102000009310 vitamin D receptors Human genes 0.000 description 1
- 108050000156 vitamin D receptors Proteins 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP3328A AUPP332898A0 (en) | 1998-05-04 | 1998-05-04 | Pharmaceutical composition |
| AU3328 | 1998-05-04 | ||
| PCT/AU1999/000323 WO1999056697A2 (en) | 1998-05-04 | 1999-05-04 | Pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002513733A JP2002513733A (ja) | 2002-05-14 |
| JP2002513733A5 true JP2002513733A5 (enExample) | 2006-03-30 |
Family
ID=3807582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000546727A Pending JP2002513733A (ja) | 1998-05-04 | 1999-05-04 | 医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6664246B2 (enExample) |
| EP (1) | EP1124557A4 (enExample) |
| JP (1) | JP2002513733A (enExample) |
| KR (1) | KR20010052305A (enExample) |
| CN (1) | CN1204893C (enExample) |
| AU (1) | AUPP332898A0 (enExample) |
| HK (1) | HK1044117B (enExample) |
| WO (1) | WO1999056697A2 (enExample) |
| ZA (1) | ZA200006953B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087350A (en) | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
| US7129230B2 (en) * | 2001-03-12 | 2006-10-31 | Nestec S.A. | Method and product for treating cancer in pets |
| US20050038022A1 (en) * | 2001-03-26 | 2005-02-17 | Unisearch Limited | Method for treatment of cancer and compositions for use therein |
| AUPR644301A0 (en) * | 2001-07-17 | 2001-08-09 | Unisearch Limited | Method and composition for treatment of cancer |
| US20050209551A1 (en) * | 2004-03-18 | 2005-09-22 | Takemoto Arnold C | Detoxification and breast health preparations |
| CA2558202A1 (en) * | 2006-09-14 | 2006-11-23 | Reinhold W. Vieth | Vitamin d compositions and method of administration to infants |
| ITMI20121041A1 (it) | 2012-06-15 | 2013-12-16 | Lga Biotecnologie S R L | Chemioprevenzione del cancro del colon - retto |
| CN106109476A (zh) * | 2016-06-13 | 2016-11-16 | 中山大学 | 骨化二醇作为吲哚胺2,3‑双加氧酶‑1抑制剂的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260067A (en) * | 1988-11-16 | 1993-11-09 | Xu Zheng | Cytotropic heterogeneous molecular lipids (CHML) and process for preparing the same |
| US5798345A (en) * | 1990-09-21 | 1998-08-25 | Bone Care International, Inc. | Method of inhibiting the hyperproliferation of malignant cells |
| US5486509A (en) * | 1991-06-28 | 1996-01-23 | University Of Miami | Method of preventing and treating chemotherapy-induced alopecia |
| EP0619305B1 (en) * | 1993-02-05 | 1997-06-04 | Teijin Limited | Lactone compound and process of producing thereof |
| AUPO727097A0 (en) * | 1997-06-10 | 1997-07-03 | Unisearch Limited | Method of treatment of hepatoma and pharmaceutical compositions for use therein |
| CN1090180C (zh) * | 1997-06-25 | 2002-09-04 | 帝人株式会社 | 维生素d3衍生物及其用于炎性呼吸道疾病的治疗剂 |
-
1998
- 1998-05-04 AU AUPP3328A patent/AUPP332898A0/en not_active Abandoned
-
1999
- 1999-05-04 WO PCT/AU1999/000323 patent/WO1999056697A2/en not_active Ceased
- 1999-05-04 JP JP2000546727A patent/JP2002513733A/ja active Pending
- 1999-05-04 HK HK02105428.9A patent/HK1044117B/zh not_active IP Right Cessation
- 1999-05-04 CN CNB998081574A patent/CN1204893C/zh not_active Expired - Fee Related
- 1999-05-04 EP EP99916716A patent/EP1124557A4/en not_active Withdrawn
- 1999-05-04 KR KR1020007012271A patent/KR20010052305A/ko not_active Abandoned
-
2000
- 2000-11-27 ZA ZA200006953A patent/ZA200006953B/en unknown
-
2001
- 2001-05-22 US US09/861,865 patent/US6664246B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100572958B1 (ko) | 골 강도를 증가시키기 위한2α-메틸-19-노르-20(Ｓ)-1α,25-디히드록시비타민 Ｄ3의용도 | |
| ES2274116T3 (es) | 1-alfa-hidroxi-2-metilenj-19-nor-pregnacalciferol y sus usos. | |
| AU2002322346B2 (en) | Method of treating hyperproliferative diseases using active vitamin D analogues | |
| JP2002504100A (ja) | 肝腫瘍の治療方法およびそれに使用するための医薬組成物 | |
| CN100438877C (zh) | (20S)－1α－羟基－2α－甲基和2β－甲基－19－去甲－维生素D3及它们的用途 | |
| Trump et al. | Vitamin D compounds: clinical development as cancer therapy and prevention agents | |
| JP2002516299A5 (enExample) | ||
| JP2001511768A (ja) | 活性型ビタミンｄ類似体を使用した前立腺疾患の治療方法 | |
| JP2002516307A (ja) | １α−ヒドロキシ−２５−エン−ビタミンＤ、類似体及びその使用 | |
| JP2004512276A (ja) | １アルファ−ヒドロキシ−２−メチレン−１９−ノル−ホモプレグナカルシフェロール及びその療法的適用 | |
| AU2002322346A1 (en) | Method of treating hyperproliferative diseases using active vitamin D analogues | |
| JP2004509853A5 (enExample) | ||
| JP2002513733A5 (enExample) | ||
| US20020010165A1 (en) | Method of treating malignancy associated hypercalcemia using active vitamin D analogues | |
| JP2001515881A (ja) | １，３−ジヒドロキシ−２０，２０−ジアルキル−ビタミンｄ３類似体 | |
| JP2007530421A (ja) | （２０Ｓ）−１α−ヒドロキシ−２−メチレン−１９−ノル−ビタミンＤ３及びその使用 | |
| JP2007523162A (ja) | ２‐メチレン‐１９‐ノル‐２０（Ｓ）‐１α，２５‐ジヒドロキシビタミンＤ３の骨疾患の予防のための使用 | |
| JP2002537222A (ja) | カルセミック活性を持つ１９−ノル−ビタミンｄ３化合物 | |
| JP2002513733A (ja) | 医薬組成物 | |
| KR20010020343A (ko) | 비스 씨-20 측쇄를 갖는 비타민 디3 유사체 | |
| US20050063992A1 (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen | |
| MXPA06003898A (es) | Uso de 2-metilen-19-nor-20(s)-1a, 25-dihidroxivitamina d3 para incrementar las expectativas de vida de seres humanos. | |
| JP2003516402A (ja) | ３−メチル−クロマン又はチオクロマンの誘導体 | |
| HK1030144B (en) | Method for treatment of liver tumours and pharmaceutical compositions for use therein | |
| Brandt | Metabolism-related tissue-binding of halogenated hydrocarbons |